Owlet, Inc.
Close on Oct 19, 2026
- Market cap
- $118.62M
- P/E (TTM)
- –
- Dividend yield
- –
About Owlet
Measuring & Controlling Devices, NEC, SIC 3829
Owlet provides pediatric health and monitoring technology designed for home use. The company develops medical-grade wearable monitors and connected nursery products, including the over-the-counter Dream Sock pulse oximeter, the prescription-based BabySat monitor for infants requiring physician-directed tracking, the Dream Sight smart video and audio camera, and the integrated Dream Duo system. In addition to hardware and nursery accessories, Owlet offers the Owlet360 subscription service, which delivers health and sleep insights derived from pediatric datasets. Its offerings primarily serve parents, caregivers, and pediatric healthcare providers.
The company markets its products internationally and sells through direct-to-consumer digital platforms, retail partners, and healthcare distribution channels across more than thirty countries, including the United States, Canada, Australia, the United Kingdom, and members of the European Union. Over 2.5 million Owlet devices have been sold globally. Owlet does not disclose the location of its corporate headquarters in the provided text.
Summary of the business section of Owlet's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Owlet, Inc.
- Founded
- 2012
- Headquarters
- Lehi, UT
- Address
- 2940 West Maple Loop Drive, Suite 203 84048
- Phone
- (844) 334-5330
- Employees
- 108, Dec 31, 2025
- Industry
- Measuring & Controlling Devices, NEC
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, Salt Lake City, Utah
Stock & identifiers
- Ticker
- OWLT
- Exchange
- NYSE
- IPO date
- Sep 16, 2020
- Shares outstanding
- 29M, Aug 6, 2026
- Public float
- $95.60M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-14 reverse, Jul 10, 2023; 1-for-14 reverse, Jul 7, 2023
- SEC CIK
- 1816708
- CUSIP
- 69120X206
- ISIN
- US69120X2062
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Kurt Workman | President & CEO | 3,285,279 |
| Amanda Crawford | Chief Financial Officer | 212,800 |
| Zane M. Burke | Director | 134,787 |
| Marc F. Stoll | Director | 45,781 |
| Laura Durr | Director | 127,454 |
| John C. Kim | Director | 278,811 |
| Melissa Gonzales | Director | 114,690 |
| Eclipse Continuity Fund I, L.P. | Director | 28,492,332 |
| Lior Susan | Director | 5,665,669 |
| Eclipse Continuity GP I, LLC | Director | – |
| Eclipse Ventures Fund I, L.P. | Director | 5,665,669 |
| Eclipse Ventures GP I, LLC | Director | – |
| Eclipse Early Growth GP I, LLC | Director | – |
| Eclipse Early Growth Fund I, L.P. | Director | 1,066,472 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Jonathan Harris | $4.23M | $7.73M | $2.42M | $207 | – |
| FY2025 Kurt Workman | $799.41K | $1.25M | $2.42M | $207 | – |
| FY2024 Kurt Workman | $987.07K | $920.15K | $1.07M | $57 | – |
| FY2023 Kurt Workman | $269.13K | -$88.45K | $687.40K | $67 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had 108 full-time employees and 6 part-time employees.”
Corporate history
Events identified from SEC filings